Top

Journal of Translational Medicine

Published in:

Open Access 01-12-2022 | Septicemia | Research

Effects of hydrogen-rich saline in neuroinflammation and mitochondrial dysfunction in rat model of sepsis-associated encephalopathy

Authors: John Sieh Dumbuya, Siqi Li, Lili Liang, Yanchen Chen, Jiang Du, Qiyi Zeng

Published in: Journal of Translational Medicine | Issue 1/2022

Abstract

Background

Sepsis-associated encephalopathy (SAE) is one of the most common types of sepsis-related organ dysfunction without overt central nervous system (CNS) infection. It is associated with higher mortality, low quality of life, and long-term neurological sequelae in suspected patients. At present there is no specific treatment for SAE rather than supportive therapy and judicious use of antibiotics, which are sometimes associated with adverse effects. Molecular hydrogen (H2) has been reported to play crucial role in regulating inflammatory responses, neuronal injury, apoptosis and mitochondrial dysfunction in adult models of SAE. Here we report the protective effect of hydrogen-rich saline in juvenile SAE rat model and its possible underling mechanism(s).

Materials and methods

Rats were challenged with lipopolysaccharide (LPS) at a dose of 8 mg/kg injected intraperitoneally to induce sepsis and hydrogen-rich saline (HRS) administered 1 h following LPS induction at a dose of 5 ml/kg. Rats were divided into: sham, sham + HRS, LPS and LPS + HRS. At 48 h, rats were sacrificed and Nissl staining for neuronal injury, TUNEL assay for apoptotic cells detection, immunohistochemistry, and ELISA protocol for inflammatory cytokines determination, mitochondrial dysfunction parameters, electron microscopy and western blot analysis were studied to examine the effect of HRS in LPS-induced septic rats.

Results

Rats treated with HRS improved neuronal injury, improvement in rats’ survival rate. ELISA analysis showed decreased TNF-α and IL-1β and increased IL-10 expression levels in the HRS-treated group. Apoptotic cells were decreased after HRS administration in septic rats. The numbers of GFAP and IBA-1positive cells were attenuated in the HRS-treated group when compared to the LPS group. Subsequently, GFAP and IBA-1 immunoreactivity were decreased after HRS treatment. Mitochondrial membrane potential detected by JC-1 dye and ATP content were decreased in septic rats, which were improved after HRS treatment, while release of ROS was increased in the LPS group reverted by HRS treatment, ameliorating mitochondrial dysfunction. Further analysis by transmission electron microscopy showed decreased number of mitochondria and synapses, and disrupted mitochondrial membrane ultrastructure in the LPS group, while HRS administration increased mitochondria and synapses number.

Conclusion

These data demonstrated that HRS can improve survival rate, attenuate neuroinflammation, astrocyte and microglial activation, neuronal injury and mitochondrial dysfunction in juvenile SAE rat model, making it a potential therapeutic candidate in treating paediatric SAE.

Matics TJ, Sanchez-Pinto LN. Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically Ill children. JAMA Pediatr. 2017;171(10):e172352. https://doi.org/10.1001/jamapediatrics.2017.2352.CrossRefPubMedPubMedCentral

Schlapbach LJ, Straney L, Bellomo R, MacLaren G, Pilcher D. Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit. Intensive Care Med. 2018;44(2):179–88. https://doi.org/10.1007/s00134-017-5021-8.CrossRefPubMed

Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, De Luca D, Deep A, Faust SN, De Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, Møller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(Suppl 1):10–67. https://doi.org/10.1007/s00134-019-05878-6.CrossRefPubMedPubMedCentral

Zhao YZ, Gao ZY, Ma LQ, Zhuang YY, Guan FL. Research on biogenesis of mitochondria in astrocytes in sepsis-associated encephalopathy models. Eur Rev Med Pharmacol Sci. 2017;21(17):3924–34.PubMed

Sanz D, D’Arco F, Robles CA, Brierley J. Incidence and pattern of brain lesions in paediatric septic shock patients. Br J Radiol. 2018;91(1084):20170861. https://doi.org/10.1259/bjr.20170861.CrossRefPubMedPubMedCentral

Yang Y, Liang S, Geng J, Wang Q, Wang P, Cao Y, Li R, Gao G, Li L. Development of a nomogram to predict 30 day mortality of patients with sepsis-associated encephalopathy: a retrospective cohort study. J Intensive Care. 2020;2(8):45. https://doi.org/10.1186/s40560-020-00459-y.CrossRef

Sandquist MK, Clee MS, Patel SK, Howard KA, Yunger T, Nagaraj UD, Jones BV, Fei L, Vadivelu S, Wong HR. High frequency of neuroimaging abnormalities among pediatric patients with sepsis who undergo neuroimaging. Pediatr Crit Care Med. 2017;18(7):607–13. https://doi.org/10.1097/PCC.0000000000001173.CrossRefPubMedPubMedCentral

Kaur J, Singhi P, Singhi S, Malhi P, Saini AG. Neurodevelopmental and behavioral outcomes in children with sepsis-associated encephalopathy admitted to pediatric intensive care unit: a prospective case control study. J Child Neurol. 2016;31(6):683–90. https://doi.org/10.1177/0883073815610431.CrossRefPubMed

Nwafor DC, Brichacek AL, Mohammad AS, Griffith J, Lucke-Wold BP, Benkovic SA, Geldenhuys WJ, Lockman PR, Brown CM. Targeting the blood-brain barrier to prevent sepsis-associated cognitive impairment. J Cent Nerv Syst Dis. 2019;9(11):1179573519840652. https://doi.org/10.1177/1179573519840652.CrossRef

10.

Helbing DL, Böhm L, Witte OW. Sepsis-associated encephalopathy. CMAJ. 2018;190(36):E1083. https://doi.org/10.1503/cmaj.180454.CrossRefPubMedPubMedCentral

11.

Ziaja M. Septic encephalopathy. Curr Neurol Neurosci Rep. 2013;13(10):383. https://doi.org/10.1007/s11910-013-0383-y.CrossRefPubMedPubMedCentral

12.

Huang L, Peng S, Li R, Xie D, Huang D. Fulminant encephalopathy in a child with hyperferritinemic sepsis: a case report. BMC Neurol. 2020;20(1):73. https://doi.org/10.1186/s12883-020-01661-z.CrossRefPubMedPubMedCentral

13.

Czempik PF, Pluta MP, Krzych ŁJ. Sepsis-associated brain dysfunction: a review of current literature. Int J Environ Res Public Health. 2020;17(16):5852. https://doi.org/10.3390/ijerph17165852.CrossRefPubMedPubMedCentral

14.

Ebersoldt M, Sharshar T, Annane D. Sepsis-associated delirium. Intensive Care Med. 2007;33(6):941–50. https://doi.org/10.1007/s00134-007-0622-2.CrossRefPubMed

15.

Ehler J, Petzold A, Wittstock M, Kolbaske S, Gloger M, Henschel J, Heslegrave A, Zetterberg H, Lunn MP, Rommer PS, Grossmann A, Sharshar T, Richter G, Nöldge-Schomburg G, Sauer M. The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy—a prospective, pilot observational study. PLoS ONE. 2019;14(1):e0211184. https://doi.org/10.1371/journal.pone.0211184.CrossRefPubMedPubMedCentral

16.

Chaudhry N, Duggal AK. Sepsis associated encephalopathy. Adv Med. 2014;2014:762320. https://doi.org/10.1155/2014/762320.CrossRefPubMedPubMedCentral

17.

Hadem J, Hafer C, Schneider AS, Wiesner O, Beutel G, Fuehner T, Welte T, Hoeper MM, Kielstein JT. Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients. BMC Anesthesiol. 2014;7(14):24. https://doi.org/10.1186/1471-2253-14-24.CrossRef

18.

Spapen H, Nguyen DN, Troubleyn J, Huyghens L, Schiettecatte J. Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock. Crit Care. 2010;14(2):R54. https://doi.org/10.1186/cc8947.CrossRefPubMedPubMedCentral

19.

Barancik M, Kura B, LeBaron TW, Bolli R, Buday J, Slezak J. Molecular and cellular mechanisms associated with effects of molecular hydrogen in cardiovascular and central nervous systems. Antioxidants (Basel). 2020;9(12):1281. https://doi.org/10.3390/antiox9121281.CrossRefPubMed

20.

Hu Q, Zhou Y, Wu S, Wu W, Deng Y, Shao A. Molecular hydrogen: a potential radioprotective agent. Biomed Pharmacother. 2020;130:110589. https://doi.org/10.1016/j.biopha.2020.110589.CrossRefPubMed

21.

Iida A, Nosaka N, Yumoto T, Knaup E, Naito H, Nishiyama C, Yamakawa Y, Tsukahara K, Terado M, Sato K, Ugawa T, Nakao A. The clinical application of hydrogen as a medical treatment. Acta Med Okayama. 2016;70(5):331–7. https://doi.org/10.18926/AMO/54590.CrossRefPubMed

22.

Ren JD, Wu XB, Jiang R, Hao DP, Liu Y. Molecular hydrogen inhibits lipopolysaccharide-triggered NLRP3 inflammasome activation in macrophages by targeting the mitochondrial reactive oxygen species. Biochim Biophys Acta. 2016;1863(1):50–5. https://doi.org/10.1016/j.bbamcr.2015.10.012.CrossRefPubMed

23.

Yang M, Dong Y, He Q, Zhu P, Zhuang Q, Shen J, Zhang X, Zhao M. Hydrogen: a novel option in human disease treatment. Oxid Med Cell Longev. 2020;5(2020):8384742. https://doi.org/10.1155/2020/8384742.CrossRef

24.

Xie K, Liu L, Yu Y, Wang G. Hydrogen gas presents a promising therapeutic strategy for sepsis. Biomed Res Int. 2014;2014:807635. https://doi.org/10.1155/2014/807635.CrossRefPubMedPubMedCentral

25.

Qiu P, Liu Y, Zhang J. Recent advances in studies of molecular hydrogen against sepsis. Int J Biol Sci. 2019;15(6):1261–75. https://doi.org/10.7150/ijbs.30741.CrossRefPubMedPubMedCentral

26.

Muramatsu Y, Ito M, Oshima T, Kojima S, Ohno K. Hydrogen-rich water ameliorates bronchopulmonary dysplasia (BPD) in newborn rats. Pediatr Pulmonol. 2016;51(9):928–35. https://doi.org/10.1002/ppul.23386.CrossRefPubMed

27.

Bai X, Liu S, Yuan L, Xie Y, Li T, Wang L, Wang X, Zhang T, Qin S, Song G, Ge L, Wang Z. Hydrogen-rich saline mediates neuroprotection through the regulation of endoplasmic reticulum stress and autophagy under hypoxia-ischemia neonatal brain injury in mice. Brain Res. 2016;1(1646):410–7. https://doi.org/10.1016/j.brainres.2016.06.020.CrossRef

28.

Shao A, Wu H, Hong Y, Tu S, Sun X, Wu Q, Zhao Q, Zhang J, Sheng J. Hydrogen-rich saline attenuated subarachnoid hemorrhage-induced early brain injury in rats by suppressing inflammatory response: possible involvement of NF-κB pathway and NLRP3 inflammasome. Mol Neurobiol. 2016;53(5):3462–76. https://doi.org/10.1007/s12035-015-9242-y.CrossRefPubMed

29.

Spulber S, Edoff K, Hong L, Morisawa S, Shirahata S, Ceccatelli S. Molecular hydrogen reduces LPS-induced neuroinflammation and promotes recovery from sickness behaviour in mice. PLoS One. 2012;7(7):e42078. https://doi.org/10.1371/journal.pone.0042078.CrossRefPubMedPubMedCentral

30.

Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13(6):688–94. https://doi.org/10.1038/nm1577.CrossRefPubMed

31.

Li GM, Ji MH, Sun XJ, Zeng QT, Tian M, Fan YX, Li WY, Li N, Yang JJ. Effects of hydrogen-rich saline treatment on polymicrobial sepsis. J Surg Res. 2013;181(2):279–86. https://doi.org/10.1016/j.jss.2012.06.058.CrossRefPubMed

32.

Yao L, Chen H, Wu Q, Xie K. Hydrogen-rich saline alleviates inflammation and apoptosis in myocardial I/R injury via PINK-mediated autophagy. Int J Mol Med. 2019;44(3):1048–62. https://doi.org/10.3892/ijmm.2019.4264.CrossRefPubMedPubMedCentral

33.

Li D, Ai Y. Hydrogen saline suppresses neuronal cell apoptosis and inhibits the p38 mitogen-activated protein kinase-caspase-3 signaling pathway following cerebral ischemia-reperfusion injury. Mol Med Rep. 2017;16(4):5321–5. https://doi.org/10.3892/mmr.2017.7294.CrossRefPubMedPubMedCentral

34.

Sobue S, Yamai K, Ito M, Ohno K, Ito M, Iwamoto T, Qiao S, Ohkuwa T, Ichihara M. Simultaneous oral and inhalational intake of molecular hydrogen additively suppresses signaling pathways in rodents. Mol Cell Biochem. 2015;403(1–2):231–41. https://doi.org/10.1007/s11010-015-2353-y.CrossRefPubMed

35.

Wang L, Yin Z, Wang F, Han Z, Wang Y, Huang S, Hu T, Guo M, Lei P. Hydrogen exerts neuroprotection by activation of the miR-21/PI3K/AKT/GSK-3β pathway in an in vitro model of traumatic brain injury. J Cell Mol Med. 2020;24(7):4061–71. https://doi.org/10.1111/jcmm.15051.CrossRefPubMedPubMedCentral

36.

Chen H, Mao X, Meng X, Li Y, Feng J, Zhang L, Zhang Y, Wang Y, Yu Y, Xie K. Hydrogen alleviates mitochondrial dysfunction and organ damage via autophagy-mediated NLRP3 inflammasome inactivation in sepsis. Int J Mol Med. 2019;44(4):1309–24. https://doi.org/10.3892/ijmm.2019.4311.CrossRefPubMedPubMedCentral

37.

Iketani M, Ohsawa I. molecular hydrogen as a neuroprotective agent. Curr Neuropharmacol. 2017;15(2):324–31. https://doi.org/10.2174/1570159x14666160607205417.CrossRefPubMedPubMedCentral

38.

Ke H, Liu D, Li T, Chu X, Xin D, Han M, Wang S, Wang Z. Hydrogen-rich saline regulates microglial phagocytosis and restores behavioral deficits following hypoxia-ischemia injury in neonatal mice via the akt pathway. Drug Des Devel Ther. 2020;21(14):3827–39. https://doi.org/10.2147/DDDT.S264684.CrossRef

39.

Liu Y, Liu W, Sun X, Li R, Sun Q, Cai J, Kang Z, Lv S, Zhang JH, Zhang W. Hydrogen saline offers neuroprotection by reducing oxidative stress in a focal cerebral ischemia-reperfusion rat model. Med Gas Res. 2011;1(1):15. https://doi.org/10.1186/2045-9912-1-15.CrossRefPubMedPubMedCentral

40.

Manabe T, Rácz I, Schwartz S, Oberle L, Santarelli F, Emmrich JV, Neher JJ, Heneka MT. Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing. J Neurochem. 2021;159(3):525–42. https://doi.org/10.1111/jnc.15491.CrossRefPubMed

41.

Mazeraud A, Righy C, Bouchereau E, Benghanem S, Bozza FA, Sharshar T. Septic-associated encephalopathy: a comprehensive review. Neurotherapeutics. 2020;17(2):392–403. https://doi.org/10.1007/s13311-020-00862-1.CrossRefPubMedPubMedCentral

42.

Chen J, Shi X, Diao M, Jin G, Zhu Y, Hu W, Xi S. A retrospective study of sepsis-associated encephalopathy: epidemiology, clinical features and adverse outcomes. BMC Emerg Med. 2020;20(1):77. https://doi.org/10.1186/s12873-020-00374-3.CrossRefPubMedPubMedCentral

43.

Catarina AV, Branchini G, Bettoni L, De Oliveira JR, Nunes FB. Sepsis-associated encephalopathy: from pathophysiology to progress in experimental studies. Mol Neurobiol. 2021;58(6):2770–9. https://doi.org/10.1007/s12035-021-02303-2.CrossRefPubMed

44.

Brochu ME, Girard S, Lavoie K, Sébire G. Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: an experimental study. J Neuroinflammation. 2011;20(8):55. https://doi.org/10.1186/1742-2094-8-55.CrossRef

45.

James Anitha, Patel Vaishali. Hypoxic ischaemic encephalopathy. Paediatrics And Child Health. 2014;24:9. https://doi.org/10.1016/j.paed.2014.02.003.CrossRef

46.

Zhang W, Zhu L, An C, et al. The blood brain barrier in cerebral ischemic injury—disruption and repair. Brain Hemorrhages. 2020. https://doi.org/10.1016/j.hest.2019.12.004.CrossRefPubMedPubMedCentral

47.

Zhuang X, Yu Y, Jiang Y, Zhao S, Wang Y, Su L, Xie K, Yu Y, Lu Y, Lv G. Molecular hydrogen attenuates sepsis-induced neuroinflammation through regulation of microglia polarization through an mTOR-autophagy-dependent pathway. Int Immunopharmacol. 2020;81:106287. https://doi.org/10.1016/j.intimp.2020.106287.CrossRefPubMed

48.

Ren C, Yao RQ, Zhang H, Feng YW, Yao YM. Sepsis-associated encephalopathy: a vicious cycle of immunosuppression. J Neuroinflammation. 2020;17(1):14. https://doi.org/10.1186/s12974-020-1701-3.CrossRefPubMedPubMedCentral

49.

Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008;52(3):447–56. https://doi.org/10.1016/j.neuint.2007.08.006.CrossRefPubMed

50.

Bartha AI, Foster-Barber A, Miller SP, Vigneron DB, Glidden DV, Barkovich AJ, Ferriero DM. Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome. Pediatr Res. 2004;56(6):960–6. https://doi.org/10.1203/01.PDR.0000144819.45689.BB.CrossRefPubMed

51.

Chen H, Xie K, Han H, Li Y, Liu L, Yang T, Yu Y. Molecular hydrogen protects mice against polymicrobial sepsis by ameliorating endothelial dysfunction via an Nrf2/HO-1 signaling pathway. Int Immunopharmacol. 2015;28(1):643–54. https://doi.org/10.1016/j.intimp.2015.07.034.CrossRefPubMed

52.

Sim M, Kim CS, Shon WJ, Lee YK, Choi EY, Shin DM. Hydrogen-rich water reduces inflammatory responses and prevents apoptosis of peripheral blood cells in healthy adults: a randomized, double-blind, controlled trial. Sci Rep. 2020;10(1):12130. https://doi.org/10.1038/s41598-020-68930-2.CrossRefPubMedPubMedCentral

53.

Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Münch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481–7. https://doi.org/10.1038/nature21029.CrossRefPubMedPubMedCentral

54.

Wolff S, Klatt S, Wolff JC, Wilhelm J, Fink L, Kaps M, Rosengarten B. Endotoxin-induced gene expression differences in the brain and effects of iNOS inhibition and norepinephrine. Intensive Care Med. 2009;35(4):730–9. https://doi.org/10.1007/s00134-009-1394-7.CrossRefPubMed

55.

Hong Y, Shao A, Wang J, Chen S, Wu H, McBride DW, Wu Q, Sun X, Zhang J. Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible role of the Akt/GSK3β signaling pathway. PLoS ONE. 2014;9(4): e96212. https://doi.org/10.1371/journal.pone.0096212.CrossRefPubMedPubMedCentral

56.

Wang P, Zhao M, Chen Z, Wu G, Fujino M, Zhang C, Zhou W, Zhao M, Hirano SI, Li XK, Zhao L. Hydrogen gas attenuates hypoxic-ischemic brain injury via regulation of the MAPK/HO-1/PGC-1a pathway in neonatal rats. Oxid Med Cell Longev. 2020;13(2020):6978784. https://doi.org/10.1155/2020/6978784.CrossRef

57.

Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360(9328):219–23. https://doi.org/10.1016/S0140-6736(02)09459-X.CrossRefPubMed

58.

Haileselassie B, Joshi AU, Minhas PS, Mukherjee R, Andreasson KI, Mochly-Rosen D. Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy. J Neuroinflammation. 2020;17(1):36. https://doi.org/10.1186/s12974-019-1689-8.CrossRefPubMedPubMedCentral

59.

Cotena S, Piazza O. Sepsis-associated encephalopathy. Transl Med UniSa. 2012;2:20–7.PubMedPubMedCentral

60.

Heming N, Mazeraud A, Verdonk F, Bozza FA, Chrétien F, Sharshar T. Neuroanatomy of sepsis-associated encephalopathy. Crit Care. 2017;21(1):65. https://doi.org/10.1186/s13054-017-1643-z.CrossRefPubMedPubMedCentral

61.

Tian Y, Zhang Y, Wang Y, Chen Y, Fan W, Zhou J, Qiao J, Wei Y. Hydrogen, a novel therapeutic molecule, regulates oxidative stress, inflammation, and apoptosis. Front Physiol. 2021;20(12):789507. https://doi.org/10.3389/fphys.2021.789507.CrossRef

62.

Moraes CA, Zaverucha-do-Valle C, Fleurance R, Sharshar T, Bozza FA, d’Avila JC. Neuroinflammation in sepsis: molecular pathways of microglia activation. Pharmaceuticals (Basel). 2021;14(5):416. https://doi.org/10.3390/ph14050416.CrossRefPubMed

63.

Michels M, Steckert AV, Quevedo J, Barichello T, Dal-Pizzol F. Mechanisms of long-term cognitive dysfunction of sepsis: from blood-borne leukocytes to glial cells. Intensive Care Med Exp. 2015;3(1):30. https://doi.org/10.1186/s40635-015-0066-x.CrossRefPubMedPubMedCentral

64.

Michels M, Ávila P, Pescador B, Vieira A, Abatti M, Cucker L, Borges H, Goulart AI, Junior CC, Barichello T, Quevedo J, Dal-Pizzol F. Microglial cells depletion increases inflammation and modifies microglial phenotypes in an animal model of severe sepsis. Mol Neurobiol. 2019;56(11):7296–304. https://doi.org/10.1007/s12035-019-1606-2.CrossRefPubMed

65.

Shulyatnikova T, Verkhratsky A. Astroglia in sepsis associated encephalopathy. Neurochem Res. 2020;45(1):83–99. https://doi.org/10.1007/s11064-019-02743-2.CrossRefPubMed

66.

English K, Shepherd A, Uzor NE, Trinh R, Kavelaars A, Heijnen CJ. Astrocytes rescue neuronal health after cisplatin treatment through mitochondrial transfer. Acta Neuropathol Commun. 2020;8(1):36. https://doi.org/10.1186/s40478-020-00897-7.CrossRefPubMedPubMedCentral

67.

Liu W, Shan LP, Dong XS, Liu XW, Ma T, Liu Z. Combined early fluid resuscitation and hydrogen inhalation attenuates lung and intestine injury. World J Gastroenterol. 2013;19(4):492–502. https://doi.org/10.3748/wjg.v19.i4.492.CrossRefPubMedPubMedCentral

68.

Zhuang K, Zuo YC, Sherchan P, Wang JK, Yan XX, Liu F. Hydrogen inhalation attenuates oxidative stress related endothelial cells injury after subarachnoid hemorrhage in rats. Front Neurosci. 2020;21(13):1441. https://doi.org/10.3389/fnins.2019.01441.CrossRef

69.

Jiang Y, Zhang K, Yu Y, Wang Y, Lian N, Xie K, Yu Y. Molecular hydrogen alleviates brain injury and cognitive impairment in a chronic sequelae model of murine polymicrobial sepsis. Exp Brain Res. 2020;238(12):2897–908. https://doi.org/10.1007/s00221-020-05950-4.CrossRefPubMed

Title: Effects of hydrogen-rich saline in neuroinflammation and mitochondrial dysfunction in rat model of sepsis-associated encephalopathy
Authors: John Sieh Dumbuya
Siqi Li
Lili Liang
Yanchen Chen
Jiang Du
Qiyi Zeng
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Septicemia
Septicemia
Encephalopathy
Published in: Journal of Translational Medicine / Issue 1/2022
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/s12967-022-03746-4

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2022

Ophthalmic artery changes in type 2 diabetes with and without acute coronary syndrome

Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinoma

Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors

SOX21-AS1 activated by STAT6 promotes pancreatic cancer progression via up-regulation of SOX21

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage